Comparison of cardiovascular risk factors between children and adolescents with classes III and IV obesity: findings from the APV cohort.


Journal

International journal of obesity (2005)
ISSN: 1476-5497
Titre abrégé: Int J Obes (Lond)
Pays: England
ID NLM: 101256108

Informations de publication

Date de publication:
05 2021
Historique:
received: 17 04 2020
accepted: 21 01 2021
revised: 05 01 2021
pubmed: 9 4 2021
medline: 24 12 2021
entrez: 8 4 2021
Statut: ppublish

Résumé

Obesity is associated with many cardiovascular risk factors (CVRF) in childhood. There is an ongoing discussion whether there is a linear relationship between degree of overweight and deterioration of CVRFs justifying body mass index (BMI) cut-offs for treatment decisions. We studied the impact of BMI-SDS on blood pressure, lipids, and glucose metabolism in 76,660 children (aged 5-25 years) subdivided in five groups: overweight (BMI-SDS 1.3 to <1.8), obesity class I (BMI-SDS 1.8 to <2.3), class II (BMI-SDS 2.3-2.8), class III (BMI-SDS > 2.8-3.3), and class IV (BMI-SDS > 3.3). Analyses were stratified by age and sex. We found a relationship between BMI-SDS and blood pressure, triglycerides, HDL cholesterol, liver enzymes, and the triglycerides-HDL-cholesterol ratio at any age and sex. Many of these associations lost significance when comparing children with obesity classes III and IV: In females < 14 years and males < 12 years triglycerides and glucose parameters did not differ significantly between classes IV and III obesity. Prevalence of dyslipidemia was significantly higher in class IV compared to class III obesity only in females ≥ 14 years and males ≥ 12 years but not in younger children. In girls < 14 years and in boys of any age, the prevalences of type 2 diabetes mellitus did not differ between classes III and IV obesity. Since a BMI above the highest BMI cut-off was not associated consistently with dyslipidemia and disturbed glucose metabolism in every age group both in boys and girls, measurements of CVRFs instead of BMI cut-off seem preferable to guide different treatment approaches in obesity such as medications or bariatric surgery.

Identifiants

pubmed: 33828223
doi: 10.1038/s41366-021-00773-x
pii: 10.1038/s41366-021-00773-x
pmc: PMC8081660
doi:

Substances chimiques

Lipids 0
Triglycerides 0
Glucose IY9XDZ35W2

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1061-1073

Références

Han JC, Lawlor DA, Kimm SY. Childhood obesity. Lancet. 2010;375:1737–48.
doi: 10.1016/S0140-6736(10)60171-7
Juonala M, Magnussen CG, Berenson GS, Venn A, Burns TL, Sabin M. et al. Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J Med. 2011;365:1876–85.
doi: 10.1056/NEJMoa1010112
Twig G, Yaniv G, Levine H, Leiba A, Goldberger N, Derazne E, et al. Body-mass index in 2.3 million adolescents and cardiovascular death in adulthood. N Engl J Med. 2016;374:2430–40.
doi: 10.1056/NEJMoa1503840
Skinner AC, Perrin EM, Moss LA, Skelton JA. Cardiometabolic risks and severity of obesity in children and young adults. N Engl J Med. 2015;373:1307–17.
doi: 10.1056/NEJMoa1502821
Chu NF, Rimm EB, Wang DJ, Liou HS, Shieh SM. Clustering of cardiovascular disease risk factors among obese schoolchildren: the Taipei Children Heart Study. Am J Clin Nutr. 1998;67:1141–6.
doi: 10.1093/ajcn/67.6.1141
Csabi G, Torok K, Jeges S, Molnar D. Presence of metabolic cardiovascular syndrome in obese children. Eur J Pediatr. 2000;159:91–4.
doi: 10.1007/PL00013812
Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics. 1999;103:1175–82.
doi: 10.1542/peds.103.6.1175
I’Allemand D, Wiegand S, Reinehr T, Müller J, Wabitsch M, Widhalm K, et al. Cardiovascular risk in 26,008 European overweight children as established by a multicenter database. Obesity. 2008;16:1672–9.
doi: 10.1038/oby.2008.259
Reinehr T, Wolters B, Knop C, Lass N, Holl RW. Strong effect of pubertal status on metabolic health in obese children: a longitudinal study. J Clin Endocrinol Metab. 2015;100:301–8.
doi: 10.1210/jc.2014-2674
Zabarsky G, Beek C, Hagman E, Pierpont B, Caprio S, Weiss R. Impact of severe obesity on cardiovascular risk factors in youth. J Pediatr. 2018;192:105–14.
doi: 10.1016/j.jpeds.2017.09.066
Fried M, Yumuk V, Oppert JM, Torres A, Weiner R, Yashkov Y, et al. Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Surg. 2014;24:42–55.
doi: 10.1007/s11695-013-1079-8
Styne DM, Arslanian SA, Connor EL, Farooqi IS, Murad MH, Silverstein JH, et al. Pediatric obesity-assessment, treatment, and prevention: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2017;102:709–57.
doi: 10.1210/jc.2016-2573
German Obesity Association. Guidelines of the German working group on obese children and adolescents. www.a-g-a.de/Leitlinie.pdf . assessed Jan 2020.
Reinehr T, Wabitsch M, Andler W, Beyer P, Böttner A, Chen-Stute A, et al. Medical care of obese children and adolescents. APV: a standardised multicentre documentation derived to study initial presentation and cardiovascular risk factors in patients transferred to specialised treatment institutions. Eur J Pediatr. 2004;163:308–12.
doi: 10.1007/s00431-004-1421-1
Cole TJ, Lobstein T. Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity. Pediatr Obes. 2012;7:284–94.
doi: 10.1111/j.2047-6310.2012.00064.x
Cole TJ. The LMS method for constructing normalized growth standards. Eur J Clin Nutr. 1990;44:45–60.
pubmed: 2354692
Rosenbauer J, Dost A, Karges B, Hungele A, Stahl A, Bächle C, et al. Improved metabolic control in children and adolescents with type 1 diabetes: a trend analysis using prospective multicenter data from Germany and Austria. Diabetes Care. 2012;35:80–6.
doi: 10.2337/dc11-0993
Zeitler P, Arslanian S, Fu J, Pinhas-Hamiel O, Reinehr T, Tandon N, et al. ISPAD Clinical Practice Consensus Guidelines 2018: type 2 diabetes mellitus in youth. Pediatr Diabetes. 2018;19 Suppl 27:28–46..
Guidelines of the German paediatric working group on metabolic disorders. https://www.awmf.org/leitlinien/detail/ll/027-068.html . assessed Jan 2020.
Rao G. Diagnosis, epidemiology, and management of hypertension in children. Pediatrics. 2016;138:e20153616.
doi: 10.1542/peds.2015-3616
Neuhauser HK, Thamm M, Ellert U, Hense HW, Rosario AS. Blood pressure percentiles by age and height from nonoverweight children and adolescents in Germany. Pediatrics. 2011;127:e978–88.
doi: 10.1542/peds.2010-1290
Bulik-Sullivan B, Finucane HK, Anttila V, Gusev A, Day FR, Loh PR. An atlas of genetic correlations across human diseases and traits. Nat Genet. 2015;47:1236–41.
doi: 10.1038/ng.3406
Weiss R. Fat distribution and storage: how much, where, and how? Eur J Endocrinol. 2007;157 Suppl 1:S39–45.
doi: 10.1530/EJE-07-0125
Klingensmith GJ, Lanzinger S, Tamborlane WV, Hofer SE, Cheng P, de Beaufort C. et al. Adolescent type 2 diabetes: comparing the Pediatric Diabetes Consortium and Germany/Austria/Luxemburg Pediatric Diabetes Prospective registries. Pediatr Diabetes. 2018;19:1156–63.
doi: 10.1111/pedi.12712
Allard P, Delvin EE, Paradis G, Hanley JA, O'Loughlin J, Lavallée C. et al. Distribution of fasting plasma insulin, free fatty acids, and glucose concentrations and of homeostasis model assessment of insulin resistance in a representative sample of Quebec children and adolescents. Clin Chem. 2003;49:644–9.
doi: 10.1373/49.4.644
Reinehr T, Lass N, Toschke C, Rothermel J, Lanzinger S, Holl RW. Which amount of BMI-SDS reduction is necessary to improve cardiovascular risk factors in overweight children? J Clin Endocrinol Metab. 2016;101:3171–9.
doi: 10.1210/jc.2016-1885
Danielsson P, Kowalski J, Ekblom O, Marcus C. Response of severely obese children and adolescents to behavioral treatment. Arch Pediatr Adolesc Med. 2012;166:1103–8.
doi: 10.1001/2013.jamapediatrics.319
Knop C, Singer V, Uysal Y, Schaefer A, Wolters B, Reinehr T. Extremely obese children respond better than extremely obese adolescents to lifestyle interventions. Pediatr Obes. 2015;10:7–15.
doi: 10.1111/j.2047-6310.2013.00212.x
Reinehr T, Widhalm K, l’Allemand D, Wiegand S, Wabitsch M, Holl RW. Two-year follow-up in 21,784 overweight children and adolescents with lifestyle intervention. Obesity. 2009;17:1196–9.
doi: 10.1038/oby.2009.17

Auteurs

Thomas Reinehr (T)

Department of Pediatric Endocrinology, Diabetes and Nutrition Medicine, Vestische Hospital for Children and Adolescents Datteln, University of Witten/Herdecke, Witten, Germany. T.Reinehr@kinderklinik-datteln.de.

Sascha R Tittel (SR)

German Center for Diabetes Research, Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany.

Rolf Holle (R)

Institute for Medical Informatics, Biometry and Epidemiology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.

Susanna Wiegand (S)

Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Ines Gellhaus (I)

Consensus Group Obesity Training for Children and Young Adults, Rehabilitation Clinic for Children and Adolescents, Sylt, Germany.

Johannes Hebebrand (J)

Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Susanne Greber-Platzer (S)

Comprehensive Center Pediatrics, Department of Pediatrics and Adolescent Medicine, Division of Pediatric Pulmonology, Allergology and Endocrinology, Medical University Vienna, Vienna, Austria.

Christian Denzer (C)

Department of Pediatrics and Adolescent Medicine, Division of Pediatric Endocrinology and Diabetes, University Medical Center Ulm, Ulm, Germany.

Sabine Linke (S)

Katholisches Kinderkrankenhaus WILHELMSTIFT gGmbH, Children's Hospital, Hamburg, Germany.

Wieland Kiess (W)

University of Leipzig, Hospital for Children and Adolescents, Leipzig, Germany.

Reinhard W Holl (RW)

German Center for Diabetes Research, Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH